Efficacy of Osteoporosis Treatment in Men
Author Information
Author(s): Peter Schwarz, Jorgensen Niklas Rye, Mosekilde Leif, Vestergaard Peter
Primary Institution: Research Center of Aging and Osteoporosis, Department of Medicine, Glostrup Hospital, Denmark
Hypothesis
The study aims to evaluate the efficacy of osteoporosis treatments in men, particularly focusing on fracture risk reduction.
Conclusion
The evidence for medical osteoporosis treatment in men is limited and inconclusive, primarily based on small studies showing increases in bone mineral density (BMD) without clear fracture prevention outcomes.
Supporting Evidence
- Five studies showed an increase in BMD with antiresorptive treatments.
- Three studies of anabolic treatment with teriparatide showed significant increases in spine BMD.
- All evidence is based on small RCT studies with inconclusive fracture prevention outcomes.
Takeaway
This study looked at how well osteoporosis treatments work for men, but found that there isn't enough good evidence to say they really help prevent fractures.
Methodology
A systematic review and meta-analysis of randomized, placebo-controlled trials assessing the efficacy of osteoporosis treatments in men over 50 years old.
Potential Biases
The small sample sizes and lack of large-scale studies may introduce bias in the findings.
Limitations
The study is limited by the small number of included studies and the short follow-up duration, which affects the ability to draw definitive conclusions.
Participant Demographics
Men aged over 50 years with primary osteoporosis.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 3.5–5.6%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website